APO RESEARCH · REPORT
Cardiopulmonary Autotransfusion System
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Product & engineering
Understand the product.
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
Selected research
Market Structure
Global Cardiopulmonary Autotransfusion System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
Read the full market overview
This report provides an overview of the global Cardiopulmonary Autotransfusion System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cardiopulmonary Autotransfusion System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cardiopulmonary Autotransfusion System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiopulmonary Autotransfusion System market size, projected growth trends, production technologies, key applications, and end-use industries.
Cardiopulmonary Autotransfusion System Segment by Company
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Cardiopulmonary Autotransfusion System Segment by Type
Unwashed ATS
Washed ATS
Cardiopulmonary Autotransfusion System Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
Cardiopulmonary Autotransfusion System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiopulmonary Autotransfusion System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiopulmonary Autotransfusion System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiopulmonary Autotransfusion System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cardiopulmonary Autotransfusion System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiopulmonary Autotransfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cardiopulmonary Autotransfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Unwashed ATS
- Washed ATS
Applications
- Heart Surgery
- Great Organ Transplant Surgery
- Other Surgery
Companies covered
- Haemonetics
- Medtronic
- LivaNova
- Fresenius Kabi
- Terumo
- Wandong Health Sources
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cardiopulmonary Autotransfusion System Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cardiopulmonary Autotransfusion System Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cardiopulmonary Autotransfusion System Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cardiopulmonary Autotransfusion System Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cardiopulmonary Autotransfusion System Market Dynamics
- 2.1 Cardiopulmonary Autotransfusion System Industry Trends
- 2.2 Cardiopulmonary Autotransfusion System Industry Drivers
- 2.3 Cardiopulmonary Autotransfusion System Industry Opportunities and Challenges
- 2.4 Cardiopulmonary Autotransfusion System Industry Restraints
3 Cardiopulmonary Autotransfusion System Market by Manufacturers
- 3.1 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturers (2021-2026)
- 3.2 Global Cardiopulmonary Autotransfusion System Sales by Manufacturers (2021-2026)
- 3.3 Global Cardiopulmonary Autotransfusion System Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cardiopulmonary Autotransfusion System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cardiopulmonary Autotransfusion System Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cardiopulmonary Autotransfusion System Manufacturers, Product Type & Application
- 3.7 Global Cardiopulmonary Autotransfusion System Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cardiopulmonary Autotransfusion System Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cardiopulmonary Autotransfusion System Players Market Share by Revenue in 2025
- 3.8.3 2025 Cardiopulmonary Autotransfusion System Tier 1, Tier 2, and Tier 3
4 Cardiopulmonary Autotransfusion System Market by Type
- 4.1 Cardiopulmonary Autotransfusion System Type Introduction
- 4.1.1 Unwashed ATS
- 4.1.2 Washed ATS
- 4.2 Global Cardiopulmonary Autotransfusion System Sales by Type
- 4.2.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cardiopulmonary Autotransfusion System Sales by Type (2021-2032)
- 4.2.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2021-2032)
- 4.3 Global Cardiopulmonary Autotransfusion System Revenue by Type
- 4.3.1 Global Cardiopulmonary Autotransfusion System Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2021-2032)
- 4.3.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2021-2032)
5 Cardiopulmonary Autotransfusion System Market by Application
- 5.1 Cardiopulmonary Autotransfusion System Application Introduction
- 5.1.1 Heart Surgery
- 5.1.2 Great Organ Transplant Surgery
- 5.1.3 Other Surgery
- 5.2 Global Cardiopulmonary Autotransfusion System Sales by Application
- 5.2.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cardiopulmonary Autotransfusion System Sales by Application (2021-2032)
- 5.2.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2021-2032)
- 5.3 Global Cardiopulmonary Autotransfusion System Revenue by Application
- 5.3.1 Global Cardiopulmonary Autotransfusion System Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2021-2032)
- 5.3.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2021-2032)
6 Global Cardiopulmonary Autotransfusion System Sales by Region
- 6.1 Global Cardiopulmonary Autotransfusion System Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cardiopulmonary Autotransfusion System Sales by Region (2021-2032)
- 6.2.1 Global Cardiopulmonary Autotransfusion System Sales by Region (2021-2026)
- 6.2.2 Global Cardiopulmonary Autotransfusion System Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cardiopulmonary Autotransfusion System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cardiopulmonary Autotransfusion System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cardiopulmonary Autotransfusion System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cardiopulmonary Autotransfusion System Revenue by Region
- 7.1 Global Cardiopulmonary Autotransfusion System Revenue by Region
- 7.1.1 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cardiopulmonary Autotransfusion System Revenue by Region (2021-2026)
- 7.1.3 Global Cardiopulmonary Autotransfusion System Revenue by Region (2027-2032)
- 7.1.4 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cardiopulmonary Autotransfusion System Revenue (2021-2032)
- 7.2.2 North America Cardiopulmonary Autotransfusion System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cardiopulmonary Autotransfusion System Revenue (2021-2032)
- 7.3.2 Europe Cardiopulmonary Autotransfusion System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cardiopulmonary Autotransfusion System Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cardiopulmonary Autotransfusion System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cardiopulmonary Autotransfusion System Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Haemonetics
- 8.1.1 Haemonetics Company Information
- 8.1.2 Haemonetics Business Overview
- 8.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio
- 8.1.5 Haemonetics Recent Developments
- 8.2 Medtronic
- 8.2.1 Medtronic Company Information
- 8.2.2 Medtronic Business Overview
- 8.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Portfolio
- 8.2.5 Medtronic Recent Developments
- 8.3 LivaNova
- 8.3.1 LivaNova Company Information
- 8.3.2 LivaNova Business Overview
- 8.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Portfolio
- 8.3.5 LivaNova Recent Developments
- 8.4 Fresenius Kabi
- 8.4.1 Fresenius Kabi Company Information
- 8.4.2 Fresenius Kabi Business Overview
- 8.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio
- 8.4.5 Fresenius Kabi Recent Developments
- 8.5 Terumo
- 8.5.1 Terumo Company Information
- 8.5.2 Terumo Business Overview
- 8.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Terumo Cardiopulmonary Autotransfusion System Product Portfolio
- 8.5.5 Terumo Recent Developments
- 8.6 Wandong Health Sources
- 8.6.1 Wandong Health Sources Company Information
- 8.6.2 Wandong Health Sources Business Overview
- 8.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio
- 8.6.5 Wandong Health Sources Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cardiopulmonary Autotransfusion System Value Chain Analysis
- 9.1.1 Cardiopulmonary Autotransfusion System Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cardiopulmonary Autotransfusion System Production Mode & Process
- 9.2 Cardiopulmonary Autotransfusion System Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cardiopulmonary Autotransfusion System Distributors
- 9.2.3 Cardiopulmonary Autotransfusion System Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst